PCML
KURA icon

Pavaki Capital Management LLC’s Kura Oncology KURA Stock Holding History

Pavaki Capital Management LLC’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Hold
30,000
– – 0.11% 107
2026
Q1 		$244K Hold
30,000
– – 0.1% 114
2025
Q4 		$312K Buy
+30,000
New +$315K 0.12% 89

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pavaki Capital Management LLC's KURA Position: Q2 2026 in Review

Pavaki Capital Management LLC held its Kura Oncology (KURA) position steady in Q2 2026 at 30,000 shares worth $329K. The position accounts for 0.11% of the portfolio, ranked #107.

Pavaki Capital Management LLC first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Pavaki Capital Management LLC held 30,000 shares of Kura Oncology worth $329K as of Q2 2026.
  • Pavaki Capital Management LLC left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up 0.11% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #107 holding.
  • Pavaki Capital Management LLC first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.